As Singapore continues along its higher value added production journey and weathers the economic storm, EPCM contractors and service providers will have to continue to adapt, innovate, and vie for a smaller piece of the pie.
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.